Our data may alert ambulatory regarding the incidence of pneumococcal strains resistant to the most common drugs due to inappropriate use of antimicrobials and also collaborate to the elaboration of pneumococcal conjugate vaccines specific to each region.
INTRODUCTION
Pneumonia is the predominant cause of death in children worldwide (Sun et al., 2011) . Streptococcus pneuoniae, the pneumococcus is not only the sole cause of lobar pneumonia but also is the commonest bacterial cause of all adult pneumonia and the common cause of bacteremia, sepsis, meningitis, sinusitis, suppurative arthritis, peritonitis and otitis media. Infection of respiratory tract leads to high morbidity and mortality in people of all ages, especially the people over 65 years of age and the children under five years of age (Abubakar et al., 2010; Akortha et al., 2010) .
It has been estimated that pneumococcal infection in very young children is responsible for up to one million deaths per year. The polysaccharide capsule and surface proteins are virulence factors (Sun et al., 2011) . Colonization of the mucosa of the upper respiratory tract is facilitated by the production of IgA protease. The cell wall and pneumolysin are involved in the intense inflammation caused by infection (Musher, 2011) .
Studies showed that in Brazil the rate of intermediate resistance to penicillin is higher than the full resistance (Levin et al., 1996; Sessegolo et al., 1994) .
The quellung reaction has contributed to epidemiological studies related to pneumococcal infection. The discovery of invasive serotypes in the community collaborates to the development of vaccines. In Brazil, the Regional Vaccine Project (SIREVA), sponsored by the Pan American Health Organization and the Ministry of Health (National Health Foundation) has indicated variation in the distribution of serotypes and antimicrobial resistance rates among regions of the country and over time (Levin et al., 1996) .
In view of the above considerations, this study was undertaken to evaluate the resistance of S. pneumoniae strains to penicillin in different samples. The strains were analyzed by conventional laboratory methods, standardized by the Clinical and Laboratory Standard Institute (CLSI). To confirm the identification and serotyping of the samples, the strains were sent to the laboratory for performing the E-test.
METHODS

Between
Biological materials were sown after collection in sodium thioglycolate, blood agar and chocolate agar. After 12-24 h of incubation at 37°C, there was growth of colonies on t he plates and turbidity in sodium thioglycolate. To test the in vitro antimicrobial susceptibility, we used the disk diffusion method.
Screening for susceptibility to penicillin was made with standardized inoculum (0.5 McFarland scale) through the diffusion method (Bauer Kirky-modified) with oxacillin 1 g of Mueller Hinton plate with 5% defibrinated blood ram. After incubation for 20-24 h in an atmosphere of CO2 at 35°C, it was done the reading of the diameter of the inhibition halo zone (measured with a ruler and the values in mm) and compared with the CLSI standardized table. If the halo of oxacillin was ≥ 20 mm it was interpreted as penicillinsensitive if the halo of oxacillin was ≤ 19 mm it was considered as presumed resistant to penicillin, and in this case it was necessary to implement the minimum inhibitory concentration (MIC) of penicillin, to determine if the isolation was penicillin-sensitive, intermediate or resistant (Levin et al., 1996; Zether et al., 2004) .
The determination of MIC was performed by the E-test method. This method is based on the diffusion of a continuous concentration gradient of an antimicrobial agent embedded in the tape on the blood agar inoculated with pneumococci and incubated for 20-24 h at 35°C in 5% CO 2 atmosphere.
The analysis was performed by observing the amount that corresponded to the intersection of the ellipse areas related to the inhibition of bacterial growth (Zether et al., 2004) . The values for interpreting the results of MIC were ≤ 0.06 mg/ml as susceptible, 0.12 to 1.0 mg/ml as resistant intermediate and 2.0 mg/ml as resistant to penicillin full level. As quality control of susceptibility testing we used a strain of Streptococcus pneumonia ATCC 49619 (Levin et al., 1996) .
Serotyping was performed through the reaction of the ITB quelling, which is based on the ability of hyperimmune serum to react with the polysaccharide capsule of the bacterium (Levin et al., 1996) . Regarding the morphologic evaluation, we noted that the colony of pneumococci on blood agar presented small size, α-hemolytic compounds and mucoid profile with concave center. In the Gram staining we observed the presence of Gram positive cocci in pairs (diplococci) with tapered morphology (similar to candle or spear). For differentiation from other α-hemolytic streptococcus we considered biochemical evidence: optochin (inhibition zone ≥ 14 mm) and Bili solubility (negative, sensitive and positive, respectively).
RESULTS
Between
We performed an in vitro susceptibility test through the disk diffusion method, which demonstrated sensitivity to the following components: erythromycin, clindamycin, vancomycin, chloramphenicol, ceftriaxone, cefotaxime, cefepime and rifampicin. In relation to oxacillin-sensitive strains we considered it as also sensitive to ampicillin, amoxicillin/ac.clavulanic acid and ampicillin/sulbactam. Resistance to trimethoprim + sulfa occurred in 12 samples, it was not done to cotrimoxazole MIC. There was a significant amount of resistance, which indicates an empirical treatment concern.
We observed that 23 strains were susceptible to penicillin (halo ≥ 20 mm) and six strains were resistant to penicillin intermediate (halo ≤ 19 mm), and no strains showed full resistance to penicillin.
All strains were sent to the Laboratory to perform the Etest and only six strains presented intermediate resistance to penicillin, which indicated that the values obtained in MICs by the E-test method ranged from 0.004 to 0.94 µ/ml. Table 1 presents the types of diseases as well as the number of cases presented at the Municipal Hospital of Paulinia. The most common clinical diagnosis was pneumonia, which was present in 23 cases (79.3%), followed by four cases of bacteremia (13.8%), and meningitis in two cases (6.9%).
Regarding the most common biological specimens investigated, we found that the identification of S. pneumoniae was higher in the blood (72.4%), corresponding to 21 samples, followed by six in pleural fluid samples (20.7%) and two samples of CSF, as presented in Figure 1 .
The analysis of resistance to oxacillin (Table 2 ) revealed that among the 29 strains tested, 23 (79.3%) were oxacillin-sensitive, six (20.7%) oxacillin-resistant, and six (100%) confirmed intermediate resistance level to penicillin. The prevalence of intermediate resistance to penicillin was obtained from children strains, 66.7% were male and 33.3% female. Furthermore, we noted that among the strains studied from blood cultures, 17 were methicillin-sensitive and methicillin-resistant. In the pleural fluid we found four oxacillin-sensitive and two oxacillin resistant. In the CSF the samples were oxacillin- sensitive. For two resistant blood samples, we performed serotyping, which was positive for the serotype 18. The rest were not serotyped.
DISCUSSION
During 15 months we investigated 29 patients admitted at the Municipal Hospital of Paulinia with pneumonia, meningitis and bacteremia. According to our data, pneumonia committed 79.3% of patients, bacteremia and meningitis committed 6.9% and 13.8%, respectively. The highest positivity rate of pneumococci in biological samples occurred in July 2007, in a total of six samples, all sensitive to oxacillin. In this period there were two deaths from pneumonia and one with septicemia.
According to the literature, some types of pneumonia were associated with various ailments such as urinary tract infection, septicemia, respiratory tract infection, diarrhea and other diseases (Podschum and Ullmann, 1988) . Nonetheless, we did not find any association between those variables and the disease in our study.
Most patients had pneumonia as the underlying disease and co-morbidity patients presented adult alcoholism, renal failure, diabetes and cancer and were smokers. The children presented anemia, asthma and disability in swallowing. Community acquired pneumonia is an important cause of morbidity and mortality worldwide. Lower respiratory tract infections, including pneumonia, ranked third amongst the 20 leading causes of death by the World Health Organization (WHO), causing an estimated 429.2 million episodes of illness worldwide in 2004. Lower respiratory tract infections were also the leading cause of burden of disease measured in terms of disability-adjusted life years (defined by WHO as one lost year of 'healthy' life, and the burden of disease as a measurement of the gap between current health status and an ideal situation where everyone lives into old age, free of disease and disability) amongst all age groups worldwide, accounting for 94.5 million disabilityadjusted life years in 2004 (Song et al., 2011; Abubaka et al., 2011) . In this context, previous reports indicated that respiratory infections increase with age. The incidence of Pneumonia was six-fold higher in adults in Finland aged ≥75 years old compared with adults aged 30-44 years old. In rural Thailand, the incidence of pneumonia increased after 55 years old (Olsen et al., 2006) . Our data are supported by the literature, since the population investigated in our study was predominantly adult.
For treatment, we used the following drugs: cephalothin/chloramphenicol ampilicila/sub-activity (Unasyn ®), gatifloxacin, ceftriaxone, Unasyn®/ceftriaxone, oxacillin/vancomycin, crystalline penicillin, oxacillin and cephalothin. It was not indicated trimethoprim-sulfa treatment, because it showed an important resistance index. For pneumococcal meningitis it was administered ceftriaxone, which is a 3 rd generation cephalosporin that has been a good alternative for treatment. In relation to cephalosporin, enterobacter aerogenes produces an inducible chromosome-encoded AmpC cephalosporinase. Most AmpC-type β-lactamases naturally produced by Gram-negative organisms hydrolyse amino-and ureido-penicillins, cephamycins (cefoxitin and cefotetan) and, to a lesser extent, oxyimino-cephalosporins (such as ceftazidime) and monobactams (Preston et al., 2000) . Zwitterionic cephalosporins (cefepime and cefpirome), together with carbapenems, are usually excluded from the spectrum of activity of AmpC β-lactamases. However, natural cephalosporinases possessing broadened substrate activity have been reported in Enterobacteriaceae, P. aeruginosa and Acinetobacter baumannii. These extended-spectrum AmpC cephalosporinases confer reduced susceptibility to all cephalosporins. They differ from regular cephalosporinases by amino acid substitutions, insertions or deletions in four specific regionsthe Ω loop, the H-10 helix, the H-2 helix and the Cterminal extremity of the protein-all located in the vicinity of the active site (Rodriguez-Martinez et al., 2009 ). Moreover, an increased resistance to antibiotics has been reported in Pneumoniae as the widespread use of the third generation cephalosporins, β-lactam and broadspectrum antibiotics (Kamatchi et al., 2009; Zhou et al., 2011) .
The mechanism of action of penicillin to inhibit growth of microorganisms includes the inhibition of cell wall synthesis and activation of the endogenous autolytic bacteria. The action of penicillin depends on the cell wall that contains peptidoglycan in its composition. During the process of bacterial replication, penicillin inhibits the enzymes that make the link between the peptide chains and, therefore, prevents the development of the peptidoglycan structure. These enzymes (transpeptidase, carboxypeptidase and endopeptidase) are located just below the cell wall and are called penicillin binding proteins (PBPs). The ability to penetrate the cell wall and the affinity of these proteins with penicillin determine its antibacterial activity. Besides the action on the cell wall, it is considered the action of penicillin in the activation of the endogenous autolytic bacteria, causing their death and subsequent lysis (Laudano, 2011) .
As a mechanism of escape from penicillin, pneumococcus changes the structures of PBPs, which are targets for binding of beta-lactam antibiotics. Decreasing the binding affinity of this antibiotic for PBPs a biochemical change occurs which leads to decreased affinity of the drug at the site, preventing the antibiotic to reach that goal (Reinert et al., 2010) .
For the treatment of S. pneumoniae with intermediate resistance to penicillin therapy penicillin was recommended as first choice as well as G cefotaxime or ceftriaxone, or alternative drugs such as levofloxacin, grepafloxacin and vancomycin. All antibiotics from the beta-lactam group used for the treatment, present bactericidal activity (Biek et al., 2010) . In our study, all susceptibility tests performed in vitro through disk diffusion method, showed 100% sensitivity to erythromycin, vancomycin, rifampicin, chloramphenicol, cefotaxime, ceftriaxone and cefepime. Furthermore, all those which were sensitive to oxacillin also showed sensitivity to ampicillin, ampicillin/sulbactam and amoxicillin/ ac.clavulanic. In total, 10 strains, 10 hemoculture and two pleural fluids were resistant to cotrimoxazole (trimethoprim + sulfa) and MIC was not done for this drug as the treatment of these patients was not based on this drug treatment.
Comparing the results obtained in our study with those found in the literature, there was an increase of intermediate penicillin resistance in the strains analyzed, indicating that the increase in the indiscriminate use of antimicrobials is an important factor to be valued in drug therapies (Nagai et al., 2000) .
Our investigation points out the importance of the knowledge regarding the antimicrobial resistance and serotyping of pneumococcal strains, in order to monitor the effectiveness of the treatment and profile of the microorganism in this population, comparing them with other profiles in the region. We may help to reveal the best treatment and which type of immunization (vaccine) is more suitable for the region and also advise the limited and prudent use of antibiotics.
Conclusion
Based on our data, we alert the incidence of resistant pneumococcal strains to the most common drugs due to inappropriate use of antimicrobials. Our data collaborate to the formulation of specific pneumococcal conjugate vaccines to each region.
